Last reviewed · How we verify
Cryotherapy alone
At a glance
| Generic name | Cryotherapy alone |
|---|---|
| Also known as | Cryosurgery |
| Sponsor | Icahn School of Medicine at Mount Sinai |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Endorotor Resection In Refractory Barrett's Dysplasia Patients (NA)
- Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With (N)STEMI or Unstable Angina (NA)
- CRYO-1: Cryoablation in Elderly Patients With Early-Stage Breast Cancer. (NA)
- Topical Cryotherapy and Keloid/Hypertrophic Scars (PHASE3)
- Necrosectomy With Cryotechnology for Accelerated Removal (NA)
- Intercostal Nerve Cryotherapy in Patients Undergoing Minimally Invasive Pulmonary Resection (NA)
- Effect of Cryotherapy on Anesthetic Success and Pain in Irreversible Pulpitis (NA)
- Oral Cryotherapy to Decrease Taste Changes in Prostate Cancer Patients Receiving Taxane Chemotherapy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Cryotherapy alone CI brief — competitive landscape report
- Cryotherapy alone updates RSS · CI watch RSS
- Icahn School of Medicine at Mount Sinai portfolio CI